Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2857-42-3

Post Buying Request

2857-42-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2857-42-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2857-42-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,5 and 7 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2857-42:
(6*2)+(5*8)+(4*5)+(3*7)+(2*4)+(1*2)=103
103 % 10 = 3
So 2857-42-3 is a valid CAS Registry Number.
InChI:InChI=1/C21H30O4/c1-13(23)25-15-7-10-21(12-22)14(11-15)3-4-16-17-5-6-19(24)20(17,2)9-8-18(16)21/h3,15-18,22H,4-12H2,1-2H3/t15-,16-,17-,18-,20-,21+/m0/s1

2857-42-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (1E)-1-[(4-iodophenyl)methylidene]indene

1.2 Other means of identification

Product number -
Other names 3|A-Hydroxyetio-5-cholenic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2857-42-3 SDS

2857-42-3Relevant articles and documents

Synthesis of estrone via a thallium(III)-mediated fragmentation of a 19-hydroxy-androst-5-ene precursor

Kocovsky,Baines

, p. 6139 - 6140 (1993)

Estrone (6) has been synthesized from 1, an industrial precursor of androstane steroids, in seven steps. Key features of the strategy include the functionalization of C-19 (1 → 2) and a stereoelectronically controlled, Tl(III)-mediated degradation (2 → 3). Oppenauer oxidation of diol 4 then gave the unsaturated hydroxyketone 5, acid treatment of which induced aromatization affording 6.

Facile Access to Bridged Ring Systems via Point-to-Planar Chirality Transfer: Unified Synthesis of Ten Cyclocitrinols

Wang, Yu,Ju, Wei,Tian, Hailong,Sun, Suyun,Li, Xinghui,Tian, Weisheng,Gui, Jinghan

supporting information, p. 5021 - 5033 (2019/03/26)

Bridged ring systems are found in a wide variety of biologically active molecules including pharmaceuticals and natural products. However, the development of practical methods to access such systems with precise control of the planar chirality presents considerable challenges to synthetic chemists. In the context of our work on the synthesis of cyclocitrinols, a family of steroidal natural products, we herein report the development of a point-to-planar chirality transfer strategy for preparing bridged ring systems from readily accessible fused ring systems. Inspired by the proposed pathway for biosynthesis of cyclocitrinols from ergosterol, our strategy involves a bioinspired cascade rearrangement, which enabled the gram-scale synthesis of a common intermediate in nine steps and subsequent unified synthesis of 10 cyclocitrinols in an additional one to three steps. Our work provides experimental support for the proposed biosynthetic pathway and for the possible interrelationships between members of the cyclocitrinol family. In addition to being a convenient route to 5(10→19)abeo-steroids, our strategy also offers a generalized approach to bridged ring systems via point-to-planar chirality transfer. Mechanistic investigations suggest that the key cascade rearrangement involves a regioselective ring scission of a cyclopropylcarbinyl cation rather than a direct Wagner-Meerwein rearrangement.

COMPOUNDS AND METHODS FOR TREATING NEOPLASIA

-

Page/Page column 94, (2012/02/13)

The invention features compounds, pharmaceutical compositions and methods useful for the treatment of neoplasia. In particular embodiments, the compounds of the invention are useful for the treatment of multidrug resistant neoplasia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2857-42-3